Display options
Cite
White CM. Faulty Cell Lines Can Befuddle Clinical Pharmacology Decision-Making. J Clin Pharmacol. 2020;doi: 10.1002/jcph.1569.
White, C. M. (2020). Faulty Cell Lines Can Befuddle Clinical Pharmacology Decision-Making. Journal of clinical pharmacology, . https://doi.org/10.1002/jcph.1569
White, C Michael. "Faulty Cell Lines Can Befuddle Clinical Pharmacology Decision-Making." Journal of clinical pharmacology vol. (2020). doi: https://doi.org/10.1002/jcph.1569
White CM. Faulty Cell Lines Can Befuddle Clinical Pharmacology Decision-Making. J Clin Pharmacol. 2020 Jan 25; doi: 10.1002/jcph.1569. Epub 2020 Jan 25. PMID: 31981467.
Copy Download .nbib Format: NLM
Share it on

J Clin Pharmacol. 2020 Jan 25; doi: 10.1002/jcph.1569. Epub 2020 Jan 25.

Faulty Cell Lines Can Befuddle Clinical Pharmacology Decision-Making.

Journal of clinical pharmacology

C Michael White

Affiliations

  1. University of Connecticut School of Pharmacy and Hartford Hospital, Storrs, Connecticut, USA.

PMID: 31981467 DOI: 10.1002/jcph.1569

[No abstract available.]

References

  1. White CM. A review of human studies assessing cannabidiol's (CBD) therapeutic actions and potential. J Clin Pharmacol. 2019;59(7):923-934. - PubMed
  2. White CM. Mephedrone and 3,4-Methylenedioxypyrovalerone (MDPV): synthetic cathinones with serious health implications. J Clin Pharmacol. 2016;56(11):1319-1325. - PubMed
  3. White CM. How MDMA's pharmacology and pharmacokinetics drive desired effects and harms. J Clin Pharmacol. 2014;54(3):245-252. - PubMed
  4. ASCPT. What Is Clinical Pharmacology? https://www.ascpt.org/Resources/Knowledge-Center/What-is-Clinical-Pharmacology. Accessed November 8, 2019. - PubMed
  5. Bowman CM, Benet LZ. In Vitro-In Vivo Inaccuracy: The CYP3A4 anomaly. Drug Metab Disp. 2019;47(12):1368-1371. - PubMed
  6. Vcelar S, Jadhav V, Melcher M, et al. Karyotype variation of CHO host cell lines over time in culture characterized by chromosome counting and chromosome painting. Biotechnol Bioeng. 2018;115(1):165-173. - PubMed
  7. Stepanenko AA, Dmitrenko VV. HEK293 in cell biology and cancer research: phenotype, karyotype, tumorigenicity, and stress-induced genome-phenotype evolution. Gene. 2015;569(2):182-190. - PubMed
  8. Neimark J. Line of attack. Science. 2015;347(6225):938-940. - PubMed
  9. Buehring GC, Eby EA, Eby MJ. Cell line cross-contamination: how aware are mammalian cell culturists of the problem and how to monitor it? In Vitro Cell Dev Biol Anim. 2004;40(7):211-215. - PubMed
  10. Capes-Davis A, Theodosopoulos G, Atkin I, et al. Check your cultures! A list of cross-contaminated or misidentified cell lines. Int J Cancer. 2010;127(1):1-8. - PubMed
  11. Lin LC, Elkashty O, Ramamoorthi M, et al. Cross-contamination of the human salivary gland HSG cell line with HeLa cells: A STR analysis study. Oral Dis. 2018;24(8):1477-1483. - PubMed
  12. Nardone RM. Curbing rampant cross-contamination and misidentification of cell lines. Future Sci. 2008;45(3):221-227. - PubMed
  13. Oransky I, Marcus A. Thousands of studies used the wrong cells, and journals are doing nothing. STAT News. July 21, 2016. https://www.statnews.com/2016/07/21/studies-wrong-cells/. Accessed November 8, 2019. - PubMed
  14. Baker M. 1,500 scientists lift the lid on reproducibility. Nature. 2016;533(7604):452-454. - PubMed
  15. ICLAC. Register of Misidentified Cell Lines. October 2018. https://iclac.org/databases/cross-contaminations/. Accessed November 8, 2019. - PubMed

Publication Types